Vanda Raises Concerns Over FDA Review Timeline for Motion Sickness Therapy Candidate
The regulator has set a target decision date of
Vanda called the
Price: 5.08, Change: +0.10, Percent Change: +2.01
MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
© 1999-2025 Midnight Trader, Inc. All rights reserved.

Related News
-
Factbox-Hedge funds, pharma CEOs on list of attendees for China business summit
Reuters - 12 minutes ago
-
China begins review of CK Hutchisons' port deal for security concerns, Bloomberg News reports
Reuters - 13 minutes ago
-
China's Nio ties up with CATL to build battery swapping network
Reuters - 11:43 PM ET 3/17/2025
-
Benzinga - 11:24 PM ET 3/17/2025
-
China renews export registrations for US pork, poultry plants in relief to farmers
Reuters - 10:59 PM ET 3/17/2025
-
China renews export registrations for US pork, poultry plants in relief to farmers
Reuters - 10:59 PM ET 3/17/2025
-
India Morning Newsletter, March 18
Reuters - 10:51 PM ET 3/17/2025